Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) ...Middle East

SAN DIEGO, Sept. 2, 2022 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that the company granted equity awards to 25 new employees with a grant date of September 1, 2022, as equity inducement awards outside of the...

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) )

Also on site :

• Country 'MVP' Refunds Entire Audience Mid-Concert and Fans 'Cannot Believe He Did That'
• With Property Seized and Federal Funding Uncertain, Montana Asbestos Clinic Fights for Its Life
• Trump fija nuevo plazo de negociación de dos semanas y desencadena esfuerzo urgente por reanudar las conversaciones con Irán